Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Carotid stenosis management: time to address the misconceptions (‘furphies’)

Improper management of carotid artery disease for stroke prevention is prevalent. Accumulating misconceptions (‘furphies’) drive the overuse of carotid artery procedures and the inappropriate use of medicines. Recognition of these furphies is essential to improve disease management and optimize patient outcomes.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Abbott, A. L. et al. Misconceptions regarding the adequacy of best medical intervention alone for asymptomatic carotid stenosis. J. Vasc. Surg. 71, 257–269 (2020).

    Article  Google Scholar 

  2. Naylor, A. R. et al. Editor’s choice — management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur. J. Vasc. Endovasc. Surg. 55, 3–81 (2018).

    CAS  Article  Google Scholar 

  3. Abbott, A. L. et al. Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke 46, 3288–3301 (2015).

    Article  Google Scholar 

  4. Batchelder, A. J. et al. Overview of primary and secondary analyses from 20 randomised controlled trials comparing carotid artery stenting with carotid endarterectomy. Eur. J. Vasc. Endovasc. Surg. 58, 479–493 (2019).

    Article  Google Scholar 

  5. Brott, T. G. et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J. Med. 363, 11–23 (2010).

    CAS  Article  Google Scholar 

  6. Halliday, A. et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 376, 1074–1084 (2010).

    Article  Google Scholar 

  7. Bonati, L. H. et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 385, 529–538 (2015).

    Article  Google Scholar 

  8. McNeil, J. J. et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N. Engl. J. Med. 379, 1509–1518 (2018).

    CAS  Article  Google Scholar 

  9. Anand, S. S. et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391, 219–229 (2018).

    CAS  Article  Google Scholar 

  10. Ganesan, A. N. et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur. Heart J. 37, 1591–1602 (2016).

    Article  Google Scholar 

Download references


A.L.A. is a neurologist who has received grants for independent research into stroke prevention from the National Health and Medical Research Council of Australia and the BUPA Health Foundation. A.L.A. is the founding member of the Faculty Advocating Collaborative and Thoughtful Carotid Artery Treatments (FACTCATS; see

Author information

Authors and Affiliations


Corresponding author

Correspondence to Anne L. Abbott.

Ethics declarations

Competing interests

The author declares no competing interests.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abbott, A.L. Carotid stenosis management: time to address the misconceptions (‘furphies’). Nat Rev Cardiol 18, 383–384 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing